Evidence & citations 3 cited values
Every value below carries the sentence it was read from.
2 sources stand behind the page.
| Field | Value | Cited text |
|---|
| Known as |
Rituximab-EU |
ClinicalTrials.gov intervention name — accepted as the source's own label NCT01643928 ↗
|
| Known as |
MabThera |
“Subjects were offered ≤3 additional courses of treatment of PF-05280586, with or without a single transition from rituximab in Europe (rituximab-EU; MabThera) or the US...” PMID 29692005 ↗ Nov 2018
|
| Route |
Intravenous |
“1000 mg IV infusion of Rituximab-EU” NCT01643928 ↗
|